Cargando…
Calcification and Oxidative Modifications Are Associated With Progressive Bioprosthetic Heart Valve Dysfunction
BACKGROUND: Bioprosthetic heart valves (BHVs), fabricated from glutaraldehyde‐pretreated bovine pericardium or porcine aortic valves, are widely used for the surgical or interventional treatment of heart valve disease. Reoperation becomes increasingly necessary over time because of BHV dysfunction....
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5524104/ https://www.ncbi.nlm.nih.gov/pubmed/28483776 http://dx.doi.org/10.1161/JAHA.117.005648 |
_version_ | 1783252421670076416 |
---|---|
author | Lee, Suengwon Levy, Robert J. Christian, Abigail J. Hazen, Stanley L. Frick, Nathan E. Lai, Eric K. Grau, Juan B. Bavaria, Joseph E. Ferrari, Giovanni |
author_facet | Lee, Suengwon Levy, Robert J. Christian, Abigail J. Hazen, Stanley L. Frick, Nathan E. Lai, Eric K. Grau, Juan B. Bavaria, Joseph E. Ferrari, Giovanni |
author_sort | Lee, Suengwon |
collection | PubMed |
description | BACKGROUND: Bioprosthetic heart valves (BHVs), fabricated from glutaraldehyde‐pretreated bovine pericardium or porcine aortic valves, are widely used for the surgical or interventional treatment of heart valve disease. Reoperation becomes increasingly necessary over time because of BHV dysfunction. METHODS AND RESULTS: Forty‐seven explanted BHV aortic valve replacements were retrieved at reoperation for clinically severe BHV dysfunction over the period 2010–2016. Clinical explant analyses of BHV leaflets for calcium (atomic absorption spectroscopy) and oxidized amino acids, per mass spectroscopy, were primary end points. Comorbidities for earlier BHV explant included diabetes mellitus and coronary artery bypass grafting. Mean calcium levels in BHV leaflets were significantly increased compared with unimplanted BHV (P<0.001); however, time to reoperation did not differ comparing calcified and noncalcified BHV. BHV dityrosine, an oxidized amino acid cross‐link, was significantly increased in the explants (227.55±33.27 μmol/mol [dityrosine/tyrosine]) but was undetectable in unimplanted leaflets (P<0.001). BHV regional analyses revealed that dityrosine, ranging from 57.5 to 227.8 μmol/mol (dityrosine/tyrosine), was detectable only in the midleaflet samples, indicating the site‐specific nature of dityrosine formation. 3‐Chlorotyrosine, an oxidized amino acid formed by myeloperoxidase‐catalyzed chlorinating oxidants, correlated with BHV calcium content in leaflet explant analyses from coronary artery bypass graft patients (r=0.62, P=0.01) but was not significantly correlated with calcification in non–coronary artery bypass graft explanted BHV. CONCLUSIONS: Both increased BHV leaflet calcium levels and elevated oxidized amino acids were associated with bioprosthesis dysfunction necessitating reoperation; however, BHV calcium levels were not a determinant of implant duration, indicating a potentially important role for oxidized amino acid formation in BHV dysfunction. |
format | Online Article Text |
id | pubmed-5524104 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-55241042017-08-02 Calcification and Oxidative Modifications Are Associated With Progressive Bioprosthetic Heart Valve Dysfunction Lee, Suengwon Levy, Robert J. Christian, Abigail J. Hazen, Stanley L. Frick, Nathan E. Lai, Eric K. Grau, Juan B. Bavaria, Joseph E. Ferrari, Giovanni J Am Heart Assoc Original Research BACKGROUND: Bioprosthetic heart valves (BHVs), fabricated from glutaraldehyde‐pretreated bovine pericardium or porcine aortic valves, are widely used for the surgical or interventional treatment of heart valve disease. Reoperation becomes increasingly necessary over time because of BHV dysfunction. METHODS AND RESULTS: Forty‐seven explanted BHV aortic valve replacements were retrieved at reoperation for clinically severe BHV dysfunction over the period 2010–2016. Clinical explant analyses of BHV leaflets for calcium (atomic absorption spectroscopy) and oxidized amino acids, per mass spectroscopy, were primary end points. Comorbidities for earlier BHV explant included diabetes mellitus and coronary artery bypass grafting. Mean calcium levels in BHV leaflets were significantly increased compared with unimplanted BHV (P<0.001); however, time to reoperation did not differ comparing calcified and noncalcified BHV. BHV dityrosine, an oxidized amino acid cross‐link, was significantly increased in the explants (227.55±33.27 μmol/mol [dityrosine/tyrosine]) but was undetectable in unimplanted leaflets (P<0.001). BHV regional analyses revealed that dityrosine, ranging from 57.5 to 227.8 μmol/mol (dityrosine/tyrosine), was detectable only in the midleaflet samples, indicating the site‐specific nature of dityrosine formation. 3‐Chlorotyrosine, an oxidized amino acid formed by myeloperoxidase‐catalyzed chlorinating oxidants, correlated with BHV calcium content in leaflet explant analyses from coronary artery bypass graft patients (r=0.62, P=0.01) but was not significantly correlated with calcification in non–coronary artery bypass graft explanted BHV. CONCLUSIONS: Both increased BHV leaflet calcium levels and elevated oxidized amino acids were associated with bioprosthesis dysfunction necessitating reoperation; however, BHV calcium levels were not a determinant of implant duration, indicating a potentially important role for oxidized amino acid formation in BHV dysfunction. John Wiley and Sons Inc. 2017-05-08 /pmc/articles/PMC5524104/ /pubmed/28483776 http://dx.doi.org/10.1161/JAHA.117.005648 Text en © 2017 The Authors. Published on behalf of the American Heart Association, Inc., by Wiley. This is an open access article under the terms of the Creative Commons Attribution‐NonCommercial‐NoDerivs (http://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made. |
spellingShingle | Original Research Lee, Suengwon Levy, Robert J. Christian, Abigail J. Hazen, Stanley L. Frick, Nathan E. Lai, Eric K. Grau, Juan B. Bavaria, Joseph E. Ferrari, Giovanni Calcification and Oxidative Modifications Are Associated With Progressive Bioprosthetic Heart Valve Dysfunction |
title | Calcification and Oxidative Modifications Are Associated With Progressive Bioprosthetic Heart Valve Dysfunction |
title_full | Calcification and Oxidative Modifications Are Associated With Progressive Bioprosthetic Heart Valve Dysfunction |
title_fullStr | Calcification and Oxidative Modifications Are Associated With Progressive Bioprosthetic Heart Valve Dysfunction |
title_full_unstemmed | Calcification and Oxidative Modifications Are Associated With Progressive Bioprosthetic Heart Valve Dysfunction |
title_short | Calcification and Oxidative Modifications Are Associated With Progressive Bioprosthetic Heart Valve Dysfunction |
title_sort | calcification and oxidative modifications are associated with progressive bioprosthetic heart valve dysfunction |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5524104/ https://www.ncbi.nlm.nih.gov/pubmed/28483776 http://dx.doi.org/10.1161/JAHA.117.005648 |
work_keys_str_mv | AT leesuengwon calcificationandoxidativemodificationsareassociatedwithprogressivebioprostheticheartvalvedysfunction AT levyrobertj calcificationandoxidativemodificationsareassociatedwithprogressivebioprostheticheartvalvedysfunction AT christianabigailj calcificationandoxidativemodificationsareassociatedwithprogressivebioprostheticheartvalvedysfunction AT hazenstanleyl calcificationandoxidativemodificationsareassociatedwithprogressivebioprostheticheartvalvedysfunction AT fricknathane calcificationandoxidativemodificationsareassociatedwithprogressivebioprostheticheartvalvedysfunction AT laierick calcificationandoxidativemodificationsareassociatedwithprogressivebioprostheticheartvalvedysfunction AT graujuanb calcificationandoxidativemodificationsareassociatedwithprogressivebioprostheticheartvalvedysfunction AT bavariajosephe calcificationandoxidativemodificationsareassociatedwithprogressivebioprostheticheartvalvedysfunction AT ferrarigiovanni calcificationandoxidativemodificationsareassociatedwithprogressivebioprostheticheartvalvedysfunction |